Enfusion (ENFN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ENFN Enfusion

Watchlist

11.340
-0.050-0.44%

Close Feb 26 16:00 ET

11.340
0.0000.00%

Post 17:38 ET

1.07BMarket Cap283.50P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Press Release: Clearwater Analytics and Enfusion Announce Expiration of Hart-Scott-Rodino Act Waiting Period For Proposed Acquisition of Enfusion
Dow Jones19:14 ET
Express News | Clearwater Analytics and Enfusion Announce Expiration of Hart-Scott-Rodino Act Waiting Period for Proposed Acquisition of Enfusion
Reuters19:14 ET
Clearwater Analytics' Enfusion Infusion Offers Compelling Value Proposition, Analyst Upgrades Stock
BenzingaFeb 20 14:31 ET
Clearwater Analytics to Launch $800 Million Senior Secured Term Loan B Facility
MT NewswiresFeb 3 08:59 ET
Express News | Clearwater Analytics Holdings: Intends to Use Proceeds From Term Loan to Fund Acquisition of Enfusion
ReutersFeb 3 07:03 ET
Clearwater Analytics' Transformative Acquisition of Enfusion Fuels Growth Potential and Market Expansion
TipRanksJan 24 02:55 ET

Comments

Teddy123

1 hour ago

Clearwater Analytics and Enfusion Announce Expiration of Hart-Scott-Rodino Act Waiting Period For Proposed Acquisition of Enfusion

$Clearwater Analytics (CWAN.US)$ $Enfusion (ENFN.US)$
Fintech Merger Advances: Clearwater-Enfusion Deal Passes Key Regulatory Test - What's Next?

Movers and Shakers

Jan 13 07:45

Columns Today's Pre-Market Movers and Top Ratings | ANF, LULU, ITCI and More

Morning Movers
Gapping up
$Lululemon Athletica (LULU.US)$ shares climbed 3.9% after the company raised its current-quarter targets, driven by strong holiday-season demand for its apparel.
$Enfusion (ENFN.US)$ shares surged 12% after Clearwater Analytics (NYSE:CWAN), which rose 1.7%, announced a $1.5 billion cash-and-stock acquisition of the investment management platform.
$Intra-Cellular Therapies (ITCI.US)$ shares skyrocketed 35% ...

snowman91

Jan 1 03:59

M&A target Jan/Feb 2025

$Enfusion (ENFN.US)$ this will be bought out anytime soon, looking at price action and options flow

Moomoo AI

Mar 13, 2024 06:45

Enfusion's decent ROE doesn't translate into growth due to a five-year net income decline. High payout ratio or poor capital allocation might be hampering growth. Despite high ROE and profit retention, earnings growth is below expectations, indicating possible external threats.

Has Enfusion, Inc.'s (NYSE:ENFN) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Movers and Shakers

Jan 30, 2024 07:14

Columns Today's Morning Movers and Top Ratings: GM, SMCI, UPS, SPOT and More

Morning Movers
Gapping up
$General Motors (GM.US)$ stock soared 7.8% after the auto giant reported lower pretax profit for the fourth quarter but gave investors an upbeat outlook for 2024 and signaled more capital could be returned to shareholders.
$Pfizer (PFE.US)$ stock rose 1.1% after the drugmaker reported a surprise quarterly profit, helped by COVID products demand being stronger than expectations and lower research costs.
$Ford Motor (F.US)$ stock ros...

Trending Stocks

Symbol Mini Chart % Chg